First Trust Advisors LP Buys New Stake in AngioDynamics, Inc. (ANGO)

First Trust Advisors LP bought a new stake in AngioDynamics, Inc. (NASDAQ:ANGO) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 28,898 shares of the medical instruments supplier’s stock, valued at approximately $494,000. First Trust Advisors LP owned approximately 0.08% of AngioDynamics at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Thomson Horstmann & Bryant Inc. acquired a new position in AngioDynamics during the 3rd quarter worth approximately $5,095,000. Broadfin Capital LLC increased its position in AngioDynamics by 14.9% during the 2nd quarter. Broadfin Capital LLC now owns 1,683,252 shares of the medical instruments supplier’s stock worth $27,286,000 after purchasing an additional 217,800 shares in the last quarter. Public Employees Retirement System of Ohio increased its position in AngioDynamics by 7.8% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 28,259 shares of the medical instruments supplier’s stock worth $458,000 after purchasing an additional 2,050 shares in the last quarter. California State Teachers Retirement System increased its position in AngioDynamics by 21.6% during the 2nd quarter. California State Teachers Retirement System now owns 64,686 shares of the medical instruments supplier’s stock worth $1,049,000 after purchasing an additional 11,500 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its position in AngioDynamics by 32.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 29,321 shares of the medical instruments supplier’s stock worth $475,000 after purchasing an additional 7,130 shares in the last quarter. Institutional investors and hedge funds own 95.29% of the company’s stock.

AngioDynamics, Inc. (NASDAQ:ANGO) opened at $17.03 on Friday. AngioDynamics, Inc. has a 12-month low of $14.80 and a 12-month high of $18.85. The company has a current ratio of 2.34, a quick ratio of 1.48 and a debt-to-equity ratio of 0.17. The stock has a market cap of $625.64, a P/E ratio of 24.70, a P/E/G ratio of 1.75 and a beta of 1.04.

AngioDynamics (NASDAQ:ANGO) last posted its earnings results on Thursday, September 28th. The medical instruments supplier reported $0.12 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.16 by ($0.04). AngioDynamics had a return on equity of 4.83% and a net margin of 1.64%. The business had revenue of $85.40 million for the quarter, compared to the consensus estimate of $86.12 million. During the same period in the previous year, the firm earned $0.17 earnings per share. The company’s revenue was down 3.1% compared to the same quarter last year. analysts anticipate that AngioDynamics, Inc. will post 0.65 earnings per share for the current year.

A number of equities analysts recently issued reports on the stock. Canaccord Genuity reiterated a “hold” rating and set a $17.00 price objective on shares of AngioDynamics in a research report on Sunday, October 8th. Zacks Investment Research upgraded shares of AngioDynamics from a “hold” rating to a “buy” rating and set a $19.00 price objective for the company in a research report on Tuesday, October 3rd. KeyCorp reiterated a “hold” rating on shares of AngioDynamics in a research report on Friday, August 25th. Finally, BidaskClub upgraded shares of AngioDynamics from a “sell” rating to a “hold” rating in a research report on Saturday, August 19th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $18.60.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Week Herald and is the property of of Week Herald. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://weekherald.com/2017/12/10/first-trust-advisors-lp-buys-new-stake-in-angiodynamics-inc-ango.html.

About AngioDynamics

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply